Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas.

BMC Oral Health · 2025 · PMC12374416 · PMID 40849665

Europe PMC DOI

hedged sentences

0.0710

closest p · 1.4× alpha

0.0770

boldest claim

The sentences

showed a trendP = 0.071so close (0.05 < p ≤ 0.1)

Meanwhile, OS also showed a trend toward worse outcomes in the EBER-negative group, albeit without significance (82.0% [95% CI, 70.3%−95.6%] vs. 89.2% [95% CI, 83.7%−95.1%], P = 0.071, Fig. 3 D).

also in 53,322 other papers

did not reach statistical significanceP = 0.077so close (0.05 < p ≤ 0.1)

However, this trend was attenuated and did not reach statistical significance after adjusting for tumor characteristics (HR: 0.522, 95% CI, 0.254–1.073, P = 0.077 in Model 2) and treatment-related factors (HR: 0.511, 95% CI, 0.248–1.050, P = 0.068 in Model 3).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.